Status:
COMPLETED
Evaluation of Salivary ELISA for Hormone Monitoring in IVF Patients
Lead Sponsor:
Instituto Valenciano de Infertilidad, IVI VALENCIA
Collaborating Sponsors:
MINT DIAGNOSTICS
Conditions:
Infertility, Female
Reproductive Sterility
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
In assisted reproductive treatment (ART), it is necessary to follow closely the stimulation cycles of patients undergoing these treatments in order to monitor the number and size of developing follicl...
Eligibility Criteria
Inclusion
- Patients undergoing IVF/ICSI treatment
- Patients planned to embryo transfer (ET) undergoing hormonal replacement therapy
- Aged from18-45 years old.
- BMI 19-30 kg/m2
- Signed written informed consent
Exclusion
- • Patients suffering for any systemic disease or endocrine disorder will be excluded foe the study
Key Trial Info
Start Date :
February 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 20 2023
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05184777
Start Date
February 3 2022
End Date
February 20 2023
Last Update
March 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IVI Valencia
Valencia, Spain, 46003